Pfizer Inc. [PFE] stock is trading at $28.51, up 0.42%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PFE shares have lost -0.83% over the last week, with a monthly amount drifted -2.76%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Pfizer Inc. [NYSE: PFE] stock has seen the most recent analyst activity on August 07, 2024, when Daiwa Securities upgraded its rating to a Outperform. Previously, Argus downgraded its rating to Hold on March 22, 2024. On February 23, 2024, Guggenheim initiated with a Buy rating and assigned a price target of $36 on the stock. TD Cowen downgraded its rating to a Market Perform but stick to its price target of $32 on January 04, 2024. Jefferies upgraded its rating to Buy for this stock on October 16, 2023, and upped its price target to $39. In a note dated July 17, 2023, JP Morgan reiterated an Neutral rating on this stock and revised its target price from $45 to $41.
Pfizer Inc. [PFE] stock has fluctuated between $25.20 and $36.29 over the past year. Currently, Wall Street analysts expect the stock to reach $46.29 within the next 12 months. Pfizer Inc. [NYSE: PFE] shares were valued at $28.51 at the most recent close of the market. An investor can expect a potential return of 62.36% based on the average PFE price forecast.
Analyzing the PFE fundamentals
Pfizer Inc. [NYSE:PFE] reported sales of 55.64B for the trailing twelve months, which represents a growth of 4.31%. Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at -0.07%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.03 and Total Capital is 0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 28.31 points at the first support level, and at 28.10 for the second support level. However, for the 1st resistance point, the stock is sitting at 28.76, and for the 2nd resistance point, it is at 29.00.
Ratios To Look Out For
For context, Pfizer Inc.’s Current Ratio is 0.86. In addition, the Quick Ratio stands at 0.60 and the Cash Ratio stands at 0.02. Considering the valuation of this stock, the price to sales ratio is 2.90, the price to book ratio is 1.84.
Transactions by insiders
Recent insider trading involved DAMICO JENNIFER B., SVP & Controller, that happened on Aug 13 ’24 when 5154.0 shares were sold. Director, Gottlieb Scott completed a deal on Dec 15 ’23 to buy 3000.0 shares.
